Magma Allianz Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.97 M
as on 16-11-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.35 Cr
as on 16-11-2024
- Revenue -19.38%
(FY 2023)
- Profit -32.11%
(FY 2023)
- Ebitda -20.04%
(FY 2023)
- Net Worth 9.21%
(FY 2023)
- Total Assets 1.60%
(FY 2023)
About Magma Allianz Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.97 M.
The company currently has active open charges totaling ₹1.35 Cr.
Ravi Sapra, Rekha Sharma, Rashita Sapra, and One other member serve as directors at the Company.
- CIN/LLPIN
U25110CH2004PLC027692
- Company No.
027692
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Magma Allianz Laboratories Limited offer?
Magma Allianz Laboratories Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Nutraceuticals & Dietary Supplements, Protein Powder, Mineral Supplement, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Magma Allianz Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Sapra  | Director | 01-Dec-2008 | Current |
| Rekha Sharma | Director | 01-Apr-2010 | Current |
| Rashita Sapra | Director | 01-Apr-2010 | Current |
| Rikesh Kumar | Director | 01-Dec-2008 | Current |
Financial Performance of Magma Allianz Laboratories.
Magma Allianz Laboratories Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.38% decrease. The company also saw a substantial fall in profitability, with a 32.11% decrease in profit. The company's net worth moved up by a moderate rise of 9.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magma Allianz Laboratories?
In 2023, Magma Allianz Laboratories had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jul 2022 | ₹3.50 M | Open |
State Bank Of India Creation Date: 14 Mar 2007 | ₹1.00 Cr | Open |
How Many Employees Work at Magma Allianz Laboratories?
Magma Allianz Laboratories has a workforce of 23 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magma Allianz Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magma Allianz Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
